Cartron, G., Letestu, R., Dartigeas, C., Tout, M., Mahé, B., Gagez, A.-L., Ferrant, E., Guiu, B., Villemagne, B., Letuan, P., Aurran, T., Orsini-Piocelle, F., Banos, A., Feugier, P., Leblond, V., de Guibert, S., Tournilhac, O., Dupuis, J., Delmer, A., Rouillé, V., Ternant, D. and Leprêtre, S. (2018) “Increased rituximab exposure does not improve response and outcome of patients with chronic lymphocytic leukemia after fludarabine, cyclophosphamide, rituximab. A French Innovative Leukemia Organization (FILO) study”, Haematologica. Pavia, Italy, 103(8), pp. e356-e359. doi: 10.3324/haematol.2017.182352.